Recombinant Human ABCA4 Protein，His

ABCA4 is a member of the ATP-binding cassette (ABC) transporter family, predominantly expressed in the retinal pigment epithelium and photoreceptor cells, where it plays a crucial role in the visual cycle. Mutations in the ABCA4 gene are linked to several severe retinal diseases, including Stargardt disease and age-related macular degeneration, leading to progressive vision loss. The ABCA4 protein is responsible for the clearance of toxic byproducts generated during phototransduction, particularly the removal of all-trans-retinal, which, if accumulated, can cause retinopathy. Given its vital function in maintaining retinal health, understanding the structure and function of ABCA4 at the molecular level is critical for developing targeted therapies for retinal diseases. Researchers are focusing on the recombinant expression and functional characterization of ABCA4 to elucidate its transport mechanisms and the impact of specific mutations on its activity. By employing techniques such as cryo-electron microscopy and site-directed mutagenesis, scientists aim to map the transport pathway and identify potential therapeutic targets. This fundamental research not only sheds light on the biochemistry of ABCA4 but also on how alterations in its function contribute to the pathogenesis of retinal disorders, paving the way for innovative treatments that could restore vision in affected individuals.